Guidelines have been compiled by The Joint Tuberculosis Committee of the British Thoracic Society to quantify the risks of reactivation of tuberculosis with anti-tumour necrosis factor alpha (anti-TNF-alpha) treatment. These guidelines are intended to inform respiratory physicians, gastroenterologists, rheumatologists and dermatologists, together with specialist nurses in those disciplines.
No takes yet. Share an insight, caveat, or question.
A 2005 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: